Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the ...

The Phase 1 trial of the mRNA vaccine candidate will assess safety, determine the dosage range and identify potential side ...

Canada's chief science adviser says the federal government should devise a way to reflect on its response to the COVID-19 ...

If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine.

Moderna begins Ebola vaccine trials in Canada for Bundibugyo strain. Phase 1 assesses safety, dosage, and side effects.

BUNIA, Congo (AP) — Wiza Bondele goes to work every day at a hospital in Congo with one goal in mind: to slow the ...

TORONTO — Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of ...

Moderna began a Phase 1 clinical trial of its experimental vaccine mRNA-1469 targeting the Bundibugyo strain of Ebola virus.

Moderna has initiated its first human trial of mRNA-1469, an experimental vaccine targeting Bundibugyo ebolavirus, with 80 ...

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines ...

The program is backed by the Coalition for Epidemic Preparedness Innovations, which has committed up to $50 million.